Lisa M Richards, MSN, CNM | |
6720 Frank Lloyd Wright Ave, Suite 103, Middleton, WI 53562-1753 | |
(608) 821-0123 | |
(608) 821-0124 |
Full Name | Lisa M Richards |
---|---|
Gender | Female |
Speciality | Advanced Practice Midwife |
Location | 6720 Frank Lloyd Wright Ave, Middleton, Wisconsin |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1467745166 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367A00000X | Advanced Practice Midwife | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Lisa M Richards, MSN, CNM 6720 Frank Lloyd Wright Ave, Suite 103, Middleton, WI 53562-1753 Ph: (608) 821-0123 | Lisa M Richards, MSN, CNM 6720 Frank Lloyd Wright Ave, Suite 103, Middleton, WI 53562-1753 Ph: (608) 821-0123 |
News Archive
Approximately two percent of Caucasians have a gene segment variation that can cause a certain form of schizophrenia. Most people with the variation, known as a polymorphism, do not have the disease. A University of Iowa Health Care study reveals a good prognosis for people who do have this form of schizophrenia.
Cell biologists at Johns Hopkins have identified a unique class of breast cancer cells that lead the process of invasion into surrounding tissues. Because invasion is the first step in the deadly process of cancer metastasis, the researchers say they may have found a weak link in cancer's armor and a possible new target for therapy.
Researchers at Boston University School of Medicine (BUSM) have found that pediatricians provided with the proper communication, educational and information technology tools and training could reduce the rates of children developing early childhood caries (ECC) or cavities by 77 percent. This study appears in the October issue of the Journal Medical Care.
A Rutgers-Camden scholar is performing research as part of a collaborative effort with Arizona State University to make significant advancements in nanotechnology.
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the availability of the HER2Sense preclinical imaging agent, to support breast cancer discovery research into personalized medicine.
› Verified 3 days ago